drugset / Trial / NCT03673956
Topical Antibiotics in Chronic Rhinosinusitis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Researchers are trying to find out if patients develop antibiotic resistant organisms after the use of topical antibiotics in the treatment of chronic rhinosinusitis.
Timeline
- Start
- 2018-09-26
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 240 mg | Intranasal |
| Subject | Mupirocin | Small molecule | 30 mg | Intranasal |
| Subject | Tobramycin | Small molecule | 240 mg | Intranasal |
| Subject | Vancomycin | Other / unclassified | 240 mg | Intranasal |